Chlorambucil-taurocholate

ID: ALA2074762

Max Phase: Preclinical

Molecular Formula: C42H67Cl2N3O7S

Molecular Weight: 828.98

Molecule Type: Small molecule

Associated Items:

Representations

Synonyms (1): Chlorambucil-taurocholate
Synonyms from Alternative Forms(1):

    Canonical SMILES:  CC(CCC(=O)NCCS(=O)(=O)O)C1CC[C@H]2[C@@H]3CC[C@@H]4C[C@@H](OCCNC(=O)CCCc5ccc(N(CCCl)CCCl)cc5)CC[C@]4(C)[C@H]3C[C@H](O)[C@]12C

    Standard InChI:  InChI=1S/C42H67Cl2N3O7S/c1-29(7-16-40(50)46-22-26-55(51,52)53)35-14-15-36-34-13-10-31-27-33(17-18-41(31,2)37(34)28-38(48)42(35,36)3)54-25-21-45-39(49)6-4-5-30-8-11-32(12-9-30)47(23-19-43)24-20-44/h8-9,11-12,29,31,33-38,48H,4-7,10,13-28H2,1-3H3,(H,45,49)(H,46,50)(H,51,52,53)/t29?,31-,33+,34+,35?,36+,37+,38+,41+,42-/m1/s1

    Standard InChI Key:  NXUMPCNHCFUSHW-KHWJWLOASA-N

    Associated Targets(Human)

    Bile acid transporter 197 Activities

    Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

    Molecule Features

    Natural Product: NoOral: NoChemical Probe: NoParenteral: No
    Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
    Chirality: NoAvailability: NoProdrug: No

    Drug Indications

    MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

    Mechanisms of Action

    Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

    Properties

    Molecular Weight: 828.98Molecular Weight (Monoisotopic): 827.4077AlogP: 6.84#Rotatable Bonds: 20
    Polar Surface Area: 145.27Molecular Species: ACIDHBA: 7HBD: 4
    #RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
    CX Acidic pKa: -1.02CX Basic pKa: 1.72CX LogP: 4.92CX LogD: 3.68
    Aromatic Rings: 1Heavy Atoms: 55QED Weighted: 0.06Np Likeness Score: 0.93

    References

    1. Kullak-Ublick GA, Glasa J, Böker C, Oswald M, Grützner U, Hagenbuch B, Stieger B, Meier PJ, Beuers U, Kramer W, Wess G, Paumgartner G..  (1997)  Chlorambucil-taurocholate is transported by bile acid carriers expressed in human hepatocellular carcinomas.,  113  (1): [PMID:9322525] [10.1053/gast.1997.v113.pm9322525]